In our September newsletter we announced that researchers at the University of Sydney had received an industry collaboration grant to investigate the use of our
Slow rate of clearance makes new product ideal for magnetic particle imaging. Imagion Biosystems Limited (ASX:IBX), a company dedicated to improving healthcare through earlier cancer
At the April 2017 Annual Meeting of the American Association for Cancer Research, we first reported our long-circulating mPEG-coated PrecisionMRX® superparamagnetic nanoparticles. Since then, we’ve refined
We have temporarily suspended our nanoparticle operations. Please revisit us in the future. We apologize for the inconvenience. Any questions, please email: info@imagionbio.com Dismiss